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INTRODUCTION 
Studies on the prevalence of respiratory tract pathogens 
colonizing the nasopharyngeal flora of children attend- 
ing day-care centers (DCCs) have been reported in a 
number of recent publications. Attending day care was 
shown to be a risk factor for the carriage of antibiotic- 
resistant strains of pneumococci [l], an observation 
most likely related to the frequent use of antibiotics in 
upper respiratory tract infections of children in this age 
group and also to other epidemiologic features unique 
to the day-care setting (behavior, immaturity of immune 
system, etc.). Such studies are of importance for at least 
two reasons. (1) Information about the prevalence of 
resistant strains carried by healthy children may be the 
basis for choosing appropriate therapy for pediatric 
upper respiratory tract infections. (2) The overwhelm- 
ing majority of drug-resistant pneumococcal strains are 
restricted to only a few of the 90 pneumococcal sero- 
types, and these serotypes are typical of the flora carried 
by children [2].  Information on the frequency and 
nature of drug-resistant pneumococci colonizing the 
nasopharynx of healthy children may provide guidance 
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as to therapeutic choices for treatment of pneumo- 
coccal invasive disease, both adult and pediatric, caused 
by drug-resistant strains. 
To our best knowledge, the Lisbon DCC studies 
to be described here represent the first surveillance of 
the prevalence of respiratory pathogens and their anti- 
biotic susceptibility profiles among healthy children in 
Portugal. The Portuguese studies differ from most other 
D C C  studies in several respects. (1) Strain characteriza- 
tion in the Portuguese study has been through mole- 
cular fingerprinting from the start because of the 
recognition that pneumococcal serotypes, the primary 
basis of strain identification in most earlier studies, are 
genetically heterogeneous. (2) The Portuguese UCC 
surveillance was planned as a sequence of studies to be 
repeated for several consecutive years, in order to allow 
detection of temporal trends and also to establish a 
‘baseline’ on the prevalence of resistance, which is 
critical for the evaluation of the effect of intervention 
studies planned for the years 1999 and 2000. (3) The 
Portuguese DCCs were designed to provide a set of 
‘observation posts’, in which the effect of reduced anti- 
biotic pressure (or other intervention) on the prevalence 
of resistant strains in the nasopharyngeal flora may be 
quantitatively evaluated. 
That antibiotics select for resistant bacteria is a 
truism needing no proof. Crude relationships between 
the prevalence rates of resistant strains among disease- 
causing bacteria and drug use in particular parts of the 
world have also been repeatedly demonstrated. An at 
least temporary decline in the frequency of resistant 
strains following reduced use of a particular antibiotic 
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was also shown in several studies. However, the long- 
range efficacy of such interventions on the prevalence 
of antibiotic-resistant respiratory pathogens in their 
ecological reservoir, i.e. among the microbial flora 
colonizing the nasopharynx of children, could be much 
more effectively evaluated in the ‘closed’ epidemiologic 
setting of DCCs. The large databank incorporating 
information on the microbiological and molecular 
profiles of Streptococcus pneumoniae recovered during 
the 3 years of the Lisbon DCC studies from a total of 
1617 children and over 2000 nasopharyngeal samples 
provides the appropriate ‘baseline’ information, on the 
basis of which the efficacy of planned intervention 
studies may be evaluated. 
In what follows, we shall provide a brief synopsis 
of the structure and mode of operation of the Lisbon 
DCC initiative and report on some relevant findings. 
Most of the data used in this paper come from a recent 
publication [3] .  
STRUCTURE OF THE LISBON DAY CARE CENTER 
INITIATIVE [3] 
Study population 
To obtain a representative sample of children, several 
DCCs representing a spectrum of demographic social 
strata were chosen from different geographic areas in 
the city (Figure 1). The 16 selected centers provided 
over 2000 nasopharyngeal samples from children 
between the ages of 6 months and 6 years. The DCCs 
were divided into three groups according to socio- 
economic status. In the most anuent class I DCCs 
parents support all expenses. In class 11, the tuition fee 
is based on family income. Class I11 DCCs are fully 
subsidised by the government. 
Approval for the study was obtained from the 
Ministry of Education and the directors of the DCCs, 
and signed informed consent was obtained from the 
parents of all participating children. 
Figure 1 Location of the 16 day care centers participating in the 1996-98 surveillance study on the map of Lisbon. 
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Figure 2 Members of the surveillance team participating 
in various aspects of the day-care center study 
The investigative team 
From the beginning, the Lisbon D C C  studies involved 
international collaboration with two groups who parti- 
cipated in the planning and evaluation of the experi- 
ments: the National University Hospital, Reykjavik, 
Iceland (Karl Kristinsson) and the Laboratory of 
Microbiology at The Rockefeller University, New 
York (Alexander Tomasz). Two clinical microbiologist 
colleagues from Iceland have been participating in the 
laboratory phase of the study (strain isolation and 
characterization at Oeiras), and most serotyping was 
performed in the laboratory of Dr Karl Kristinsson in 
Iceland. 
Figure 2 shows the names of participating colleagues 
during the years of surveillance 1996-98. 
Strain collection 
Strain collection began in 1996 in seven DCCs, and this 
number expanded to 14 in 1997 and 16 in 1998. The 
number of participating children and the number of 
respiratory tract pathogens collected and characterized 
by serologic and microbiological methods are shown in 
Table 1. 
The rest of this report will concentrate on the more 
detailed description of findings with S. pneumoniae 
isolates. 
Antibiotic resistance profiles 199&98 
Figure 3 documents the large increase in carriage of 
penicillin-resistant pneumococci between 1996 and 
1997, and the increase in the prevalence of macrolide-, 
tetracycline- and chloramphenicol-resistant isolates 
during the last 2 years of the study. 
Table 1 Carriage rates of respiratory pathogens by children in day care 
Distribution of antibiotic-resistant pneumococci in the 
seven participating DCCs during the 1996 phase of 
surveillance 
Figure 4 shows the substantial differences detected 
between individual DCCs in terms of their micro- 
biological profiles. Not only did the frequency of 
carriage of penicillin-resistant isolates vary widely, but 
DCCs also differed in the types of antibiotic-resistant 
pneumococcal strains prevalent in the particular center. 
For instance, D C C  5 appeared to be free of penicillin- 
resistant strains. In DCC 2, all antibiotic-resistant 
pneurnococcal isolates were resistant to penicillin, while 
in D C C  1, most drug-resistant strains were susceptible 
to penicillin but carried resistance genes to other anti- 
bacterial agents such as rnacrolides, sulfamethoxazole- 
trirnethoprim, tetracycline or chloraniphenicol. 
DCCs as epidemiologic units 
Characterization of the strains collected by micro- 
biological and molecular fingerprinting techniques 
can give a tremendously improved resolution to the 
microbiological characterization and also to the epi- 
demiology of S. pneumoniae strains inhabiting the 
nasopharyngeal flora of children. Tables 2-4 show a 
complete catalog of the relevant properties of anti- 
biotic-resistant pneumococci recovered from the seven 
DCCs during 1996 [3]. The tables show three groups 
of bacteria: those exhibiting ‘high’- and ‘low’-level 
penicillin resistance (Table 2) and those without 
resistance to penicillin but expressing resistance to other 
antibacterial agents. The properties used for charac- 
terization included serotype, antibiotype and PFGE 
pattern. 
Tables 2-4 demonstrate several interesting points. 
It can be seen that bacteria showing a common serotype 
may still belong to distinct and different genetic line- 
ages. Antibiotic resistance pattern represents yet another 
independent variable. AU but one of the 31 ‘highly’ 
penicillin-resistant isolates were represented by only 
two PFGE types with typical features of two inter- 
nationally spread epidemic clones of S. pneumoniae. In 
Year I X C  No. o f  children Moraxella catarrhalis Haemophilus influenzae Streptococcus pneumoniae 
1996 7 586 317 (54%) 417 (72%) 277 (47%) 
1997 12 745 409 (55%) 574 (77%) 353 (47%) 
1998 12 780 381 (49%) 676 (87%) 479 (60%) 
Total 2111 
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Figure 3 Increase in the rate of antibiotic resistance among S. pneumoniae colonizing the nasopharynx of children. Rates of 
colonization by resistant isolates are given for 1996, 1997 and 1998. Pen, penicdin; C, chloramphenicol; Ery, erythromycin; 
Da, clindamycin; Te, tetracycline; SXT, sulfamethoxazole-trimethoprim. 
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Figure 4 Distribution of S. pnelrmoniae with different antibiotic resistance patterns among the seven day-care centers. ‘Low- 
level’ penicillin resistance (as defined in De Lencastre et al [3]),  gray bars; ‘high-level’ penicillin resistance, black bars; strains 
susceptible to penicillin but resistant to some other antibiotic, white bars. Reproduced with permission from Microbial Drug 
Resistance [3]. 
d e  Cencast re  e t  a l :  
contrast, strains belonging to the group with 'low' 
penicillin resistance and the group, including penicillin- 
susceptible isolates with resistance to other antibiotics 
showed great genetic diversity. The 35 isolates with a 
low degree of penicillin resistance were represented by 
as many as 12 PFGE types and three serogroups/ 
serotypes. The 52 penicillin-susceptible strains resistant 
to other antibiotics included 17 different PFGE types 
and six serogroups. 
Perhaps the most important finding documented 
in Tables 2-4 is the apparent uniqueness of each DCC 
as far as their antibiotic-resistant pneumococci are 
concerned. Of  the 31 different genetically distinct 
piieumococcal strains, only nine were shared by more 
than one DCC. In contrast, several of the resistant 
clones showed extensive clonal spread within the DCC. 
For instance, clone H was recovered from the naso- 
pharynx of five children (total number of attendees 
colonized by pneumococci: 39). In DCC 7, as many as 
11 children were colonized by clone I3 (of 73 children 
in DCC 7). These findings suggest that the exchange 
of resistant pneumococci between attendees of the 
different DCCs was relatively rare. This and the unique 
flora of each DCC strongly suggest that, at least in 
1996, the seven DCCs were 'independent' epidemio- 
logic units [4]. 
Antibiotic usage and frequency of resistant colonizers 
Strain collection was performed in each year during the 
winter months, when carriage of respiratory pathogens 
is known to be maximal. One  or two days before strain 
collection, one of us visited the DCCs in the early 
mornings to hand out the questionnaires that would be 
given to parents when they brought their children to 
the DCCs. O n  the day prearranged for collection of 
strains, the DCC was visited by a team of two specially 
trained pediatric nurses, one of the pediatrician MDs 
participating in the survey, and one or two meinbers of 
the central research laboratory at ITQB, who collected 
the filled-in questionnaires and transferred the bacterial 
isolates in the transport medium to ITQB, where all 
microbiological and molecular characterization work 
was performed. The samples were inoculated into the 
isolation media within 4 h of collection ofstrains from 
the nasopharyngeal source. 
The questionnaire 
Questions presented to the parents were assembled in a 
manner that allowed the maximum amount of infor- 
mation and yet was realistic about the time constraints 
and knowledge about antibiotics of the parents of 
children. The questions asked were as follows. Question 
1: Is your child taking any antibiotic now? YES or NO. 
If yes, what is the name of the antibiotic? Question 2: 
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If your child is not taking antibiotics now, has the child 
taken any antibiotics within the last month? If yes, what 
were the names of the antibiotics? Question 3: Did 
your child receive repeated (three or more) courses of 
antibiotics during the last 6 months or so? If yes, what 
were they? 
Assembly of a databank 
Figure 5 illustrates a portion of the type of databank 
into which the information gathered from the DCCs 
is being assembled. Each child is identified by a number 
and an additional numerical code that identifies the age 
of the child; DCC; year of collection; carriage of S. 
pneumoniae; resistance-high or low-to penicillin; 
resistance to antibiotics other than penicillin; and the 
answers to the questionnaire. In Lisbon, children are 
often enrolled in a DCC at an early age and continue 
in the same DCC afterwards for several years, up to age 
6. Such children are also identified in the databank. 
Currently, this digitized databank contains information 
on 2111 nasopharyngeal samples of 1617 children. 
A statistically significant correlation between the pre- 
valence of antibiotic-resistant pneumococci and anti- 
biotic use during the period of collection or 1 month 
prior to it (‘yes’ to questions 1 or 2) was obtained in 
the 1996 collection. 
The major direction of the Lisbon D C C  survey is 
now the preparation for an intervention phase of the 
study, in which the use of antimicrobial agents will be 
reduced and the effect of this intervention on the 
prevalence of resistant strains will be determined. 
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157(4S), 164(4S), 
173(3S), ISl(2pE). 
185(3S), 189(2S), 
204( I S) 
- 
143(SS), 144(53), 
146(48), 147(SpH), 
149(4S), IS 1(4S), 
156(4S), ISS(4pH). 
IS9(4pH), 165(3pH), 
166(4pE). 167(3S). 
168(3pE), 169(3S), 
175(3pF), 187(IS), 
200(2S), 202(2S), 
222(2pD), 226(2PB) 
- 
I)(‘(’ I 
!4 I(3PA). 
!8 I(%), 
!83(43), 
!89(5S), 
!94(4S) 
- 
!40(3S), 
141(3PA) 
239(3S), 
144(3PA), 
247(6S). 
248(SpK), 9 ND), 
2SO(SRM), 
25 I(4PA). 
255(4S), 
257(4S). 
260(4S), 
261(SS), 
262(SS), 
265(3RBB), 
273(SRN), 
275(69). 
278(68), 
280(5S), 
282(SS), 
286(68). 
287(4S), 
28S(SS), 
291(4S), 
292(4S), 
293(4S) ’ 
Figure 5 Illustration of the digital databank currently 
being assembled from the data generated by the day-care 
center surveillance study. The numerical and letter code 
identifies (from left to right) the child (the first number), 
followed by-in parentheses-the age, type of antibiotic- 
resistant S. pneumoniae: ‘high’-level penicilhn resistant (P), 
‘low’-level penicdin resistant (p), susceptible to all 
antibiotics (S), susceptible to penican but resistant to some 
other antibacterial agent(s) (R), and clonal type (PFGE 
pattern). For instance, the first entry under DCC 1-99 
(2PB)-identifies child no. 99, who was 2 years old, and 
carried a highly penicillin-resistant pneumococcus of clonal 
type B. Data are sorted out according to day-care center 
and according to the answer obtained on the questionnaires. 
Thus, children who have been tahng antibiotics ‘now’ (i.e. 
during the surveillance) are listed in the first row of the 
figure. 
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